CVE-2014-5406:詳細資料

CVE-2014-5406

0.55%V4
2015-07-06
19h10 +00:00
A08-Soft and Data Integrity Fail
Network
2025-11-03
18h34 +00:00
指定 CVE 通知
掌握特定 CVE 的任何變更。
管理通知

CVE 描述

Hospira LifeCare PCA Infusion System

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

CVE 解決方案

ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access. Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira’s Version 7.0 is being reviewed by the FDA prior to its release. The release date for Version 7.0 of the LifeCare PCA Infusion System has not been determined. For additional information about Hospira’s new release, contact Hospira’s technical support at 1‑800-241-4002.

CVE 資訊

相關弱點

CWE-ID 弱點名稱 來源
CWE-345 Insufficient Verification of Data Authenticity
The product does not sufficiently verify the origin or authenticity of data, in a way that causes it to accept invalid data.

指標

指標 評分 嚴重程度 CVSS 向量 來源
V2 7.6 AV:N/AC:H/Au:N/C:C/I:C/A:C
V2 9.3 AV:N/AC:M/Au:N/C:C/I:C/A:C nvd@nist.gov

EPSS

EPSS 是一種預測漏洞被利用可能性的評分模型。

EPSS 評分

EPSS 模型產生介於 0 到 1(0% 到 100%)之間的概率分數。分數越高,漏洞被利用的概率越大。

EPSS 百分位數

百分位數用於根據 EPSS 分數對 CVE 進行排名。例如,EPSS 評分在第 95 百分位的 CVE 比 95% 的其他 CVE 更有可能被利用。因此,百分位數用於比較某 CVE 的 EPSS 分數與其他 CVE 的相對位置。

相關產品

設定 0

Hospira>>Lifecare_pcainfusion_firmware >> Version 至(含) 5.0

Hospira>>Lifecare_pca3 >> Version -

Hospira>>Lifecare_pca5 >> Version -

參考資料

https://ics-cert.us-cert.gov/advisories/ICSA-15-125-01
Tags : Third Party Advisory, US Government Resource